clin. canc. res.-2003-puig-5642-51
TRANSCRIPT
-
7/31/2019 Clin. Canc. Res.-2003-Puig-5642-51
1/11
2003;9:5642-5651. Published online December 3, 2003.Clin Cancer ResPere Puig, Paola Capodieci, Marija Drobnjak, et al.in Bladder Cancer
Expression Is Associated with Tumor Progressionof p73p73 Expression in Human Normal and Tumor Tissues : Loss
Updated Versionhttp://clincancerres.aacrjournals.org/content/9/15/5642
Access the most recent version of this article at:
Cited Articleshttp://clincancerres.aacrjournals.org/content/9/15/5642.full.html#ref-list-1
This article cites 29 articles, 7 of which you can access for free at:
Citing Articleshttp://clincancerres.aacrjournals.org/content/9/15/5642.full.html#related-urls
This article has been cited by 9 HighWire-hosted articles. Access the articles at:
E-mail alerts related to this article or journal.Sign up to receive free email-alerts
SubscriptionsReprints and [email protected] Department atTo order reprints of this article or to subscribe to the journal, contact the AACR
To request permission to re-use all or part of this article, contact the AACR Publications
American Association for Cancer ResearchCopyright 2003on August 10, 2012clincancerres.aacrjournals.orgDownloaded from
http://clincancerres.aacrjournals.org/content/9/15/5642http://clincancerres.aacrjournals.org/content/9/15/5642http://clincancerres.aacrjournals.org/content/9/15/5642http://clincancerres.aacrjournals.org/content/9/15/5642.full.html#ref-list-1http://clincancerres.aacrjournals.org/content/9/15/5642.full.html#ref-list-1http://clincancerres.aacrjournals.org/content/9/15/5642.full.html#ref-list-1http://clincancerres.aacrjournals.org/content/9/15/5642.full.html#related-urlshttp://clincancerres.aacrjournals.org/content/9/15/5642.full.html#related-urlshttp://clincancerres.aacrjournals.org/content/9/15/5642.full.html#related-urlshttp://clincancerres.aacrjournals.org/cgi/alertshttp://clincancerres.aacrjournals.org/cgi/alertsmailto:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]://www.aacr.org/http://www.aacr.org/http://www.aacr.org/http://clincancerres.aacrjournals.org/http://www.aacr.org/http://clincancerres.aacrjournals.org/http://www.aacr.org/http://clincancerres.aacrjournals.org/mailto:[email protected]:[email protected]://clincancerres.aacrjournals.org/cgi/alertshttp://clincancerres.aacrjournals.org/content/9/15/5642.full.html#related-urlshttp://clincancerres.aacrjournals.org/content/9/15/5642.full.html#ref-list-1http://clincancerres.aacrjournals.org/content/9/15/5642 -
7/31/2019 Clin. Canc. Res.-2003-Puig-5642-51
2/11
p73 Expression in Human Normal and Tumor Tissues: Loss of
p73 Expression Is Associated with Tumor Progression in
Bladder Cancer
Pere Puig,1 Paola Capodieci,1 Marija Drobnjak,1
David Verbel,1 Carol Prives,2
Carlos Cordon-Cardo,1 and Charles J. Di Como1
1Division of Molecular Pathology, Memorial Sloan-Kettering Cancer
Center, New York, New York, and 2Department of BiologicalSciences, Columbia University, New York, New York
ABSTRACT
Purpose: To characterize the expression profile of p73
in human normal tissues by immunohistochemistry (IHC)and to analyze the correlation between p73 expression and
bladder cancer progression.
Experimental Design: CJDp73 was characterized for
p73 detection in Western blot and IHC through its appli-
cation to isoform-transfected 293 cells. Normal tissues were
analyzed by IHC with the CJDp73 antiserum. Transitional
cell carcinoma (TCC)-derived cell lines were subjected to
reverse transcription-PCR and Western blot. TCC tissue
microarrays were analyzed for p73 expression by IHC, and
the results were statistically analyzed.
Results: p73 immunostaining was nuclear and re-
stricted to epithelial cells of certain organs such as squamous
epithelium of the epidermis and transitional epithelium ofthe bladder. The expression was also observed in certain
specialized glandular epithelia such as acinar cells of breast
and parotid gland. Four of seven TCC-derived cell lines had
low to undetectable p73 protein levels. We found undetect-
able or low p73 expression in 104 of 154 (68%) TCC cases,
this phenotype being more frequently observed in invasive
tumors when compared with superficial lesions. This asso-
ciation was statistically significant (P < 0.0001). We also
observed a significant association between p53, p63, and
p73 alterations with bladder cancer progression (P